Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
China NT Pharma Group Co., Ltd. ( (HK:1011) ) has shared an announcement.
China NT Pharma Group Co., Ltd. is transforming into a high-tech medical enterprise driven by artificial intelligence to adapt to market changes and capitalize on opportunities in China’s growing orthopedic market. The company aims to build a comprehensive healthcare ecosystem focusing on testing, treatment, and rehabilitation in bone health, leveraging AI technology and national orthopedic initiatives to ensure continued business development and provide end-to-end solutions.
The most recent analyst rating on (HK:1011) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on China NT Pharma Group Co., Ltd. stock, see the HK:1011 Stock Forecast page.
More about China NT Pharma Group Co., Ltd.
China NT Pharma Group Co., Ltd. is a diversified pharmaceutical company with nearly a decade of experience in the orthopedic health field. The company possesses extensive management expertise and a strong medical network, focusing on the development of a full-cycle intelligent healthcare ecosystem platform for bone health in China. Their primary products and services include AI-powered bone density analysis systems, orthopedic drugs, and digital healthcare services.
Average Trading Volume: 1,435,652
Technical Sentiment Signal: Buy
Current Market Cap: HK$525.9M
See more data about 1011 stock on TipRanks’ Stock Analysis page.